tion, antibody-treated animals mobilized stored neutrophils, whereas significant neutrophil mobilization did not occur in the animals which received bacteria alone until 6 h. In the animals receiving bacteria alone, exhaustion of the neutrophil supply quickly occurred (remaining storage neutrophils at 6 h, 0.2 2 0.1 X 10' cells). In contrast, animals, which received antibody, maintained an adequate supply of stored neutrophils (7.0 f 0.4 x lo6 P < 0.001). The migration of neutrophils to the site of inoculation was measured by assaying the lungs' content of myeloperoxidase, a marker enzyme for granulocytes. The right and left lungs of animals not receiving antibody accumulated the same quantity of neutrophiis, with peak pulmonary neutrophil accumulation occurring 6 h after the infection. In antibody recipients, however, the inoculated lung accumulated significantly more neutrophils than the opposite lung and peak pulmonary neutrophil accumulation occurred at 2 rather than 6 h. Abbreviations AB, antibody GBS, group B streptococci i/t, immature/total MPO, myeloperoxidase PBS, phosphate buffered saline PMN, polymorphonuclear neutrophils When newborn rats are inoculated with lo6 GBS/g body wt, a mortality rate of 90-100% characteristically occurs (1, 5, 27) . Before death, the animals invariably develop profound neutropenia, a maximal "left shift," as quantified by the imrnature/total neutrophil ratio, and exhaustion of their mature marrow neutrophi1 reserves (6) . The administration of IgM anti-type I11 GBS antibody derived from hybridoma cell lines has been demonstrated to dramatically reduce mortality in this model (29) . But the mechanism whereby this antibody provides protection from death has not been completely elucidated. We hypothesized that in addition to acting as a potent opsonin, the antibody might in some way facilitate release of stored neutrophils, or improve neutrophil migration to the site of infection. We also wondered whether animals protected from death by antibody administration would develop the profound neutropenia and neutrophil storage pool depletion characteric of neonatal animals with GBS that die (6, 7, 13) . In order to test these hypotheses, we measured the circulating and storage neutrophil pools after intrapulrnonary inoculation of either GBS alone or GBS plus antibody. In addition, we estimated the migration of neutrophils to the site of inoculation by measuring the lungs' content of myeloperoxidase, a marker enzyme for neutrophils (3, 4) .
In the present experiments, the administration of antibody had sipificakt and pre;iously undescribed effects upon the release of neutrovhils from storage sites and also on the accumulation of neutrophils in tissues."~n addition, we observed that animals protected from death by antibody administration did not develop either neutropenia or exhaustion of the mature marrow neutrophil reserves.
MATERIALS AND METHODS
Animal inoculation. Sprague Dawley albino rats (Simonson Laboratories, Gilroy, CA) were used for experimentation during the first 24 h of life. The rat pups were separated from the mothers and after washing the right lateral chest wall with povidone-iodine (Perdue Frederich Co., Nonvalk, CT) followed by 70% ethyl alcohol, the right lung was transthoracically injected with 6 microliters of bacterial suspension containing l x lo9 organism/ml, plus 1 microliter (9.0 micrograms protein) of either hybridomaderived IgM anti-type I11 GBS antibody, IgM hybridoma antibody directed against TGAL, a non-streptococcal antigen or 1 microliter of PBS. The bacterial inoculum equaled lo6 organism/g body wt and the antibody inoculum was 1.5 micrograms of protein/g body wt. Injection was accomplished with a microliter glass syringe (Hamilton Co., Whittier, CA). After the injections, animals were returned to mothers until they were sacrificed 2, 6, or 20 h later.
The type I11 GBS strain was isolated from an infected human infant, identified by the precipitin method using rabbit antisera (17) , and grown overnight at 37OC in Todd-Hewitt broth. After washing with PBS, aliquots were frozen at -70°C. Before inoculation into animals, the aliquots were thawed and grown to logarithmic phase in fresh Todd-Hewitt broth. Bacteria were then sedimented by centrifugation and the concentrated organisms were washed three times in PBS. The suspensions were then diluted in PBS to an optical density of 0.9 at 620 nm (Spectronic 20 Bausch and Lomb, Inc., Rochester, NY) producing a final concentration of 1 X 10' colony forming unit/ml.
In order to determine whether the animals inoculated with GBS and GBS + AB actually became infected, blood and pleural surface cultures were obtained 4 h after the inoculation. In addition, both the GBS and the GBS + AB used for in vivo inoculation were inoculated in vitro into fresh Todd-Hewitt broth. Hybridoma antibody preparation. The details of production and characterization of monoclonal antibodies have been described elsewhere (25) . In brief, mice were multiply immunized with live type I11 GBS (control antibody was made by multiple injections with the synthetic polypeptide TGAL). Animals were sacrificed and their spleens removed. Spleen cells were then fused with nonsecreting SP 2/0 cells using polyethylene glycol. After incubation in selective media containing hypoxanthine, aminopterin, and thymidine, antibody secreting cells were detected using an enzyme-linked irnrnunoassay (26) . Cells were cloned by limiting dilution. Nine cloned cell lines were produced. Three reacted with all GBS and six reacted only with type I11 GBS; all were IgM. Ascites was collected from animals injected intraperitoneally with hybridoma cells. Antibody preparations for these experiments were made by dialyzing ascites fluid against distilled water and resuspending the precipitate in PBS.
Quantij?cation of circulating and storage neutrophils. Two, six, and twenty hours after inoculation, animals were sacrificed. Blood neutrophil concentration was measured by cutting the external juglar vein with scissors, and obtaining 10 microliters of blood via a micropipet (Dmmmond Scientific Co., Broomall, PA), which was then diluted in cetramide (ethylhexodecyldimethylammonium bromide, Eastman Kodak Co., Rochester, NY) for electronic cell counting (Coulter Electronics, Hialeah, FL). Blood smears were stained with Wright stain and differential counts performed.
The total neutrophil storage pool and neutrophil proliferative pool were quantfied from individual animals using the methods we have previously discribed (5, 6) ; flushing the marrow from both femurs into Hank's balanced salt solution and passing the liver and spleen through sieves for nucleated cell count and differential counting.
Quantffication of lung myeloperoxidase content. Right and left lungs were removed and placed into separate glass beakers which contained 2.0 ml hexadecyltrimethylarnmonium bromide (HTAB, Sigma Chemical Co., St Louis, MO) and were then minced with scissors. The specimens were homogenized in a tissue homogenizer (Ultra Turrax, West Germany), freeze-thawed three times, sonified (Heat Systems Untrasonics Inc., Plainview, NY) and then centifuged at 40,000 x g for 15 min. The extracted myeloperoxidase was then assayed spectrophotometrically. One-tenth ml of material to be measured was mixed with 2.9 ml of 50 mM phosphate buffer, pH 6.0, containing 0.167 mg/rnl o-dianisidine dihydrochloride (Sigma Chemical Co) and 0.0005% hydrogen peroxide (Mallinckrodt, Paris, KY). These conditions were employed because, as we have previously demonstrated, they confer increased sensitivity to the assay (3, 4) . The change in absorbance at 460 nm was measured with a Beckman CU spectrophotometer (Beckman Instruments, Fullerton, CA) with a recording attachment (Gilford Instruments Laboratories., Oberlin, OH).
Data were analyzed by means of Student's t test and the Fisher Exact test.
RESULTS
The mortality observed when newborn rats were transthoracically inoculated with 1 x lo6 group B streptowcci/g body wt is shown in Figure I . Sixty-two of 66 animals inoculated with GBS alone died within 24 h of the inoculation. Similarly, 38 of 40 animals inoculated with GBS plus a control hybridoma IgM antibody (directed against TGAL) died. In contrast, no deaths were observed among 65 rats inoculated with GBS plus hybridoma-derived IgM anti-type I11 GBS antibody (GBS + AB) in a dose of 1.5 microgram/g body wt ( P < 0.005). Four hours after inoculation all animals tested grew type I11 GBS in blood and pleural surface cultures. When both GBS and GBS + AB were inoculated directly into Todd-Hewitt broth, growth of organisms invariably occurred. The changes in blood neutrophil count after inoculation with either GBS alone or GBS + AB are illustrated in Figure 2 . Two hours after inoculation the blood neutrophil concentrations were similar in the two groups, but after 6 h, animals receiving GBS alone were profoundly neutropenic (400 + 20 neutrophil/mm3) compared to GBS + AB animals (2200 +-50/ mm3, P < 0.005). After 20 h this difference was even more pronounced: the group that received GBS alone had essentially no circulating neutrophils (40 +-20/mm3) whereas GBS + AB animals maintained a blood neutrophil count within the normal range (3800 + 30/mm3, P < 0.001).
The lower panel of Figure 2 neutrophils + metamyelocytes within the bone marrow + liver + spleen) and the neutrophil proliferative pool (all myelocytes + promyelocytes + myleoblasts) in the GBS alone and GBS + AB groups are illustrated in Figure 3 . After 2 h, the GBS + AB animals had released about 50% of their neutrophil reserves. In contrast, animals receiving GBS alone had not released significant numbers of neutrophils after 2 h. Six hours after inoculation, the group of animals that received GBS alone, had released almost all of their stored neutrophils whereas the neutrophil reserves of GBS + AB animals were not exhausted ( P < 0.005). Twenty hours after the inoculation, the neutrophil reserves of animals inoculated with GBS alone were exhausted (0.1 + 0.1 X lo6 cells) in contrast to the GBS + AB group whose neutrophil reserves were only moderately diminished (7.0 +. 0.4 x lo6 cells, P < 0.001). The proliferative neutrophil pool of GBS alone animals did not differ from that of the GBS + AB group at 2,6, or 20 h, although both groups exibited values somewhat below normal after 6 h, and both increased into the normal range by 20 h.
The accumulation of neutrophils in the lungs was determined by extracting and assaying the lungs' content of MPO, 2, 6, and 20 h after the inoculation. The data are shown in Figure 4 . It can be seen that in both groups the lungs' content of myeloperoxidase increased as neutrophils accumulated in response to the infection. The group that received GBS alone accumulated neutrophils in both the right (inoculated) and left (noninoculated) lungs, and the degree of neutrophil accumulation in the two lungs did not differ at 2 or 6 h. In contrast, animals receiving GBS + AB accumulated more neutrophils in the injected lung 2 h after the inoculation.
This early accumulation of pulmonary neutrophils in GBS + AB animals coincided with earlier mobilization of neutrophils from the storage sites as shown in Figure 3 .
DISCUSSION
The unusual susceptibility of newborn infants to mortality from bacterial sepsis has been clearly demonstrated in both clinical and laboratory studies (22) . The explanation for this phenomenon appears to be complex, involving both an incomplete development of the neutrophil system (8, 14, 16, 23, 24) and lack of type-specific antibodies to major bacterial pathogens (2, 15, 21) . It is well recognized that because of these deficiencies, many neonates who contract bacterial sepsis cannot be saved with standard antibiotic therapy alone; therefore, much attention has been paid to additional, adjunctive measures, such as exchange transfusion (3 1,32) , neutrophil transfusion (9, 10, 19, 20, 33) and plasma/antibody administration (28, 30) in order to improve the outcome of these patients.
An additional measure with possible investigative as well as therapeutic ramifications was recently presented by Shigeoka and coworkers (29) . They demonstrated that administration of typespecific IgM antibody prevented mortality due to intraperitoneal GBS inoculation in neonatal rats. In the present study we wished to explore the salutory effect of this antibody and postulated that in addition to being opsonic it might also facilitate the neutrophil response because defective neutrophil supply and migration have already been demonstrated to be mechanistically important in this animal model (6, 8, 11) . We were particularly interested in determining if animals saved from death by antibody administration survived despite becoming profoundly neutropenic and neutrophil depleted or whether the antibody, in some way, protected the animals from developing neutropenia. We inoculated a group of 66 animals with GBS alone, of which 94% died. In contrast, none of 65 inoculated with GBS + AB died (P < 0.005). When animals were inoculated with GBS plus an antibody that had no affinity for the type I11 group B streptococcus, no decrease in mortality was observed. This indicates that interaction between the antibody and the bacteria was essential for protection. This observation confirms the previous report, which demonstrated the protective effect of type-specific IgM antibody and establishes the present model as a suitable one for the study of the mechanism of this phenemenon. In order to test the hypothesis that antibody might afford protection by altering or facilitating the neutrophil response, we serially measured the circulating neutrophil concentration, storage neutrophil number, and tissue (lung) neutrophil content in inoculated animals. The group receiving GBS alone exhibited profound neutropenia, a finding previously found to be associated with mortality in human and animal neonates with sepsis (6, 13) . Such neutropenia, when associated with an extreme left shift, as seen in the present experiments, correlates not only with mortality, but with exhaustion of the neutrophil stores (12) . Indeed, when the neutrophil stores were examined, the animals who received GBS alone exhibited marrow exhaustion. In contrast, animals receiving GBS + AB did not develop neutropenia, and never liberated more than 60% of their neutrophil reserves. From these observations, we conclude that the administration of type specific antibody prevented the development of neutrophil storage pool exhaustion while preventing mortality. In addition, an earlier release of neutrophils from the neutrophil storage pool occurred in the presence of antibody. Two hours after the inoculation, the antibody recipients had already released about 50% of their neutrophils reserves but non-antibody animals' reserves had not yet begun to diminish; as if the marrow did not yet recognize the presence of the large bacterial inoculum. Such a delay in mobilization of stored neutrophils might allow early bacterial proliferation and dissemination to occur. Next, we observed that released neutrophils arrived at the area of need, the right lung, in greater numbers and much more quickly when antibody was provided. This rapid release and subsequent prompt tissue accumulation of neutrophils is likely of great value in local containment and rapid elimination of the invading bacteria. The accumulation of neutrophils in the right lung of animals receiving GBS alone was never greater than that of the noninoculated, left lung. This indicates that specific migration of neutrophils toward the injected bacteria was poor in the absence of antibody. The accumulation of neutrophils in the non-injected lung may be explained however, by bilaterial pulmonary infection from intrapulmonary or hematogenous spread of organisms. Alternatively, as has been suggested by Weissmam (34) and Lash et al. (18) , perhaps the accumulation of neutrophils in the contralateral lung occurred secondary to chemotactic activation with secondary pulmonary capillary trapping of the cells. Additional studies using both killed and living organisms in neonatal and adult animals with pulmonary and extrapulmonary bacterial inoculation should provide further insight into these questions. In addition, the role of complement in this system requires elucidation.
In conclusion, the present studies confirm the protective effect of type-specific hybridoma antibody in experimental neonatal infection. In addition to acting as an opsonin, the antibody induced an earlier neutrophil response than that occurring with GBS alone. This is evidenced by an earlier release of neutrophils from the storage pool and also by a more rapid accumulation of neutrophils at the site of the bacterial inoculation. Type-specific antibody also acted to limit mobilization of storage neutrophils, whereas animals inoculated with GBS alone developed complete emptying of their neutrophil reserves with profound neutropenia and a maximal left shift. The ability of hybridoma IgM typespecific antibody to facilitate the neutrophil response in vivo and to limit neutrophil storage pool utilization may be significant in the mechanism by which animals are protected from mortality.
